Human CALP(Calprotectin) ELISA Kit
中文名称:人钙卫蛋白(CALP)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 1.56-100 ng/mL
- 灵敏度: 0.94 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人CALP抗体包被于酶标板上,实验时样品(或标准品)中的人CALP会与包被抗体结合。后依次加入生物素化的抗人CALP抗体和辣根过氧化物酶标记的亲和素,抗人CALP抗体与结合在包被抗体上的人CALP结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,CALP浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中CALP的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 1.56-100 ng/mL |
灵敏度 | 0.94 ng/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人CALP,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
IF: 4.600Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2024)Reactivity:HumanSample Type:serum,ascite tissue -
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
IF: 12.200 -
LP-004?Serum calprotectin could be a novel marker of microangiopathy in antiphospholipid syndrome patients
IF: 3.900Journal: Lupus Science & Medicine (2023)Reactivity:HumanSample Type:serum -
Calprotectin and periostin levels in periodontitis patients with coronary artery disease
IF: 3.800 -
Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
IF: 3.800 -
The use of calprotectin and other inflammatory parameters in the investigation of pseudoexfoliation syndrome concomitant glaucoma and systemic diseases
IF: 3.100 -
Can the Prognosis of COVID-19 Disease Be Determined by Fecal Markers and Cytokines?
IF: 3.657Journal: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2022)PMID:36179036Reactivity:HumanSample Type:fecal -
Peritoneal calprotectin level in peritoneal dialysis patients
IF: 2.886Journal: SEMINARS IN DIALYSIS (2022)PMID:35439838Reactivity:HumanSample Type:peritoneal dialysate drainage fluid -
Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
IF: 1.817 -
Chronic Pulmonary Aspergillosis: Disease Severity Using Image Analysis and Correlation with Systemic Proinflammation and Predictors of Clinical Outcome
IF: 5.816